Search results
Author(s):
Kahtan Fadah
,
Gregory Piazza
Added:
1 year ago
AHA 22 - CardioNerds Fellow, Dr Kahtan Fadah(Texas Tech University, US) is joined by PREVENT-HD PI, Dr Gregory Piazza (Brigham and Women's Hospital, US) to discuss the findings revealed at AHA 2022.
PREVENT-HD was designed to evaluate the safety and efficacy of rivaroxaban in reducing the risk of major venous and arterial thrombotic events in patients with COVID-19. Over 1200 patients were…
View more
Author(s):
Harriette Van Spall
,
Mandeep Mehra
Added:
4 months ago
AHA 23 - Investigator, Dr Mandeep R Mehra (Brigham and Women's Hospital and Harvard Medical School, US) is joined by Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the ARIES HM3 trial.ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were…
View more
Author(s):
Harriette Van Spall
,
John Spertus
Added:
2 years ago
Late-breaker host Dr Harriette Van Spall (McMaster University, CA) invites PI, Dr John Spertus to discuss the innovative CHIEF-HF clinical trial.
The aim of this study was to determine the superiority of the effectiveness of canagliflozin versus placebo in participants with symptomatic heart failure (HF) in improving the overall Kansas City Cardiomyopathy Questionnaire (KCCQ) Total Symptom Score …
View more
Evandro de Azambuja
Research Area(s) / Expertise:
Job title: Head of the Medical Support Team, Jules Bordet Insitute, Brussels, Belgium
Author
TCT 23: PICSO-AMI-I
Author(s):
Giovanni Luigi Di Maria
Added:
5 months ago
Video
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
Prof Nicolas Van Mieghem and Dr Joost Daemen return with their critical review series, View from the Thoraxcenter, to preview the most anticipated late-breaking and featured science trials of ACC.23.
Which trials have the potential to change practice? What are the key considerations for patient care and research? What is the context of the top trials of ACC?
Trials covered in detail include:
…
View more
Ryan J Imhoff
Author
Felipe Martínez
Research Area(s) / Expertise:
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
Learn about the key take-home messages from ACC.22 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice.
Trials covered in detail include:
00:29: PACMAN AMI:…
View more
Author(s):
Hiroyuki Daida
,
Saahil A Jumkhawala
Added:
1 year ago
AHA 22 - CardioNerds Fellow, Dr Saahil A Jumkhawala (Rutgers New Jersey Medical School, US) joins us in this collaboration between the@CardioNerdsand Radcliffe Cardiology to interviewProf Hiroyuki Daida (Juntendo Graduate School of Medicine, JP) investigator of the RESPECT EPA trial.
This randomized phase 4 trial looked at Japanese participants to assess whether long-term use of icosapent ethyl…
View more